ATE206926T1 - Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne - Google Patents

Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne

Info

Publication number
ATE206926T1
ATE206926T1 AT97112984T AT97112984T ATE206926T1 AT E206926 T1 ATE206926 T1 AT E206926T1 AT 97112984 T AT97112984 T AT 97112984T AT 97112984 T AT97112984 T AT 97112984T AT E206926 T1 ATE206926 T1 AT E206926T1
Authority
AT
Austria
Prior art keywords
acne
producing
treatment
phosphoric acid
acid diester
Prior art date
Application number
AT97112984T
Other languages
English (en)
Inventor
Kazumi Ogata
Takahiro Sakaue
Sachiko Matsuura
Masahito Iemura
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE206926T1 publication Critical patent/ATE206926T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT97112984T 1996-07-31 1997-07-29 Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne ATE206926T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20090096 1996-07-31

Publications (1)

Publication Number Publication Date
ATE206926T1 true ATE206926T1 (de) 2001-11-15

Family

ID=16432133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97112984T ATE206926T1 (de) 1996-07-31 1997-07-29 Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne

Country Status (5)

Country Link
US (1) US5807845A (de)
EP (1) EP0821962B1 (de)
AT (1) ATE206926T1 (de)
CA (1) CA2209690A1 (de)
DE (1) DE69707372T2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1262274C (zh) * 2000-11-14 2006-07-05 生命健康科学有限公司 磷酸盐衍生物复合物
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
BR0211673A (pt) * 2001-07-27 2004-07-13 Vital Health Sciences Pty Ltd Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
WO2003049774A1 (en) * 2001-12-13 2003-06-19 Vital Health Sciences Pty Ltd Transdermal transport of compounds
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
KR20050086954A (ko) * 2003-01-17 2005-08-30 바이탈 헬스 사이언시즈 피티와이 리미티드 항증식성 화합물
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
WO2005084678A1 (en) 2004-03-03 2005-09-15 Vital Health Sciences Pty Ltd Alkaloid formulations
CA2599424A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
KR20080019228A (ko) * 2005-06-17 2008-03-03 바이탈 헬스 사이언시즈 피티와이 리미티드 하나 이상의 디 및/또는 모노-(전자전달제) 인산염 유도체또는 그의 착염을 함유하는 담체
CA2631653A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
CN102821791B (zh) 2010-03-30 2015-06-17 磷肌酸有限公司 透皮递送贴剂
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
CA3007587C (en) 2015-12-09 2023-12-05 Phosphagenics Limited Pharmaceutical formulation
BR112019012946A2 (pt) 2016-12-21 2019-11-26 Avecho Biotechnology Ltd processo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
JPH0781138B2 (ja) * 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
DE4328871A1 (de) * 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
FR2715565B1 (fr) * 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
TW287103B (de) * 1994-04-22 1996-10-01 Senju Pharma Co

Also Published As

Publication number Publication date
EP0821962B1 (de) 2001-10-17
DE69707372T2 (de) 2002-04-25
DE69707372D1 (de) 2001-11-22
CA2209690A1 (en) 1998-01-31
US5807845A (en) 1998-09-15
EP0821962A1 (de) 1998-02-04

Similar Documents

Publication Publication Date Title
ATE206926T1 (de) Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
HU9600834D0 (en) Quinazoline derivatives
DE69310065T2 (de) Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
ATE173626T1 (de) Verwendung eines ascorbyl-tocopherylphosphats zur herstellung eines arzneimittels zur behandlung der pankreatitis
DE69400382T2 (de) Zusammensetzung zur Förderung des Lipidmetabolismus
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
ATE205712T1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen derivaten zur herstellung eines medikaments zur hemmung der angiogenese und angiogene krankheiten
FI102896B1 (fi) Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi
DE69413118D1 (de) Benzolsulfonamid-Derivate zur Behandlung der Blaseninstabilität
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DE69917668D1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
ATE192650T1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties